A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.
Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...
Adults with type 2 diabetes receiving tirzepatide had significantly greater declines in urine albumin-to-creatinine ratio ...
A new study published JAMA Ophthalmology has brought attention to a series of vision problems observed in patients taking ...
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small ...
A new study adds to a growing body of research suggesting a potential link between popular GLP-1 medications like Ozempic and vision loss.
Telehealth company Hims & Hers stirred up controversy by debuting a 2025 Super Bowl ad touting the benefits of its ...
A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...
Not all weight loss programs are made equal—to reach a healthy, sustainable weight, personalized programs offer the best ...